Skip to search formSkip to main contentSkip to account menu

p53 peptide vaccine

Known as: p53:264-272 Peptide, PR-147, P53 (264-272) peptide vaccine and tumor-specific mutant p53 peptide vaccine 
A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
In the nuclear medicine, beta nuclides are released during the treatment. This beta interacts with bone and muscle and produces… 
2010
2010
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Purpose: Peptide antigens have been administered…